Quadient, a company listed on Euronext Paris, has reached a new milestone. More than 300 U.S. universities now use Parcel Pending by Quadient lockers. These solutions address the growing logistical ...

Aramis Group announced robust financial results for the first half of 2025, ending March 31. Revenues reached €1,213.3 million, marking a 10% organic increase from the same period in 2024. The number ...

Forsee Power, a leader in battery systems for commercial and industrial electric vehicles, has updated its 2025 financial targets. The company reported a promising revenue increase in the first ...

Formycon AG and Fresenius Kabi announced that the U.S. FDA has granted interchangeability for FYB202/Otulfi® (ustekinumab-aauz) with Stelara®. Effective April 2025, Otulfi® can be substituted without ...

The Precia Molen Group announced consolidated revenue of €38.3 million for the first quarter of 2025, a decrease of 4% compared to the same period in 2024. Organic growth, at constant scope and ...

Leclanché SA, a major player in energy storage, announced that it has requested an extension to publish its 2024 annual report. The company missed the deadline initially set by SIX Exchange Regulation ...

On May 25, 2025, China Media Group (CMG) hosted the inaugural humanoid robot combat event in Hangzhou, showcasing robots performing martial arts moves learned from motion-captured fighters. Named the ...

Bolloré SE has announced details of its share transactions for the week of May 19-23, 2025. In total, the company acquired 2,084,308 shares at a weighted average price of €5.70142. On May 19, Bolloré ...

The Vanguard Group, Inc. has filed a Form 8.3 concerning its financial interest in Assura plc. According to the disclosure dated May 26, 2025, Vanguard holds 184,741,900 ordinary shares, representing ...

POXEL SA announced that new clinical and scientific data on TWYMEEG® will be presented at the 68th Annual Meeting of the Japan Diabetes Society, taking place May 29-31, 2025. The presentations include ...

Semperit AG Holding experienced a challenging first quarter in 2025, impacted by persistent market difficulties and uncertainties related to US tariffs. The company reported a 13.8% year-over-year ...

In the first quarter of 2025, Inventiva, a clinical-stage biopharmaceutical company, reported its financial results. As of March 31, the company held €67.9 million in cash and equivalents, down from ...